Adriana DaCosta’s experience as a student in the Duke Physician Assistant Program has opened her eyes to many things, among them the need for improved access to health care for Black and Hispanic communities.

Cardiologist Neha Pagidipati, MD, is working to improve the care of patients with cardiometabolic disease by increasing the use of evidence-based medicines.

Up to 40% of older surgery patients develop postoperative delirium, a syndrome of confusion that typically occurs in the first few days after surgery.

The new scholars are outstanding first-year students from historically under-represented or underserved backgrounds who are pursuing a PhD.

Mary Klotman, MD, talks with Dr. Michael Pencina, Professor of Biostatistics and Bioinformatics, Director of AI Health, and Duke Health’s first Chief Data Scientist about the enormous potential of Data Science and Artificial Intelligence have to improve health care, and also about how to avoid the potential pitfalls they present.

A Duke Health transplant patient decided to give back by joining OneDukeGen, the new precision medicine study that will analyze the DNA of 150,000 Duke patients and research study participants.

Duke School of Medicine Symposium on Oct. 2-3 celebrates Robert Lefkowitz's 50- year career at Duke and honors his legacy of Nobel Prize-winning insights that transformed modern medicine.

Fluvoxamine, an antidepressant, is one of four FDA-approved repurposed medications tested in ACTIV-6, a nationwide remote study.

Faculty members are exploring the use of ChatGPT in student learning environments, and their own personal research.